Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Alzheimer's Disease

Free Subscription Articles published in Exp Neurol Retrieve available abstracts of 32 articles: HTML format Text format

Single Articles

January 2010
1. TABATON M , Zhu X, Perry G, Smith MA, et al
   Signaling effect of amyloid-beta(42) on the processing of AbetaPP.
   Exp Neurol. 2010;221:18-25.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
2. PETZOLD A , Chapman MD, Schraen S, Verwey NA, et al
   Anunbiased, staged, multi-center, validationstrategy for Alzheimer's disease CSF tau levels.
   Exp Neurol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
3. JOLIVALT CG , Hurford R, Lee CA, Dumaop W, et al
   Type-1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.
   Exp Neurol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
4. HAMPEL H , Shen Y, Walsh DM, Aisen P, et al
   Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.
   Exp Neurol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
5. FONSECA AC , Resende R, Oliveira CR, Pereira CM, et al
   Cholesterol and statins in Alzheimer's disease: current controversies.
   Exp Neurol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. FOLWELL J , Cowan CM, Ubhi KK, Shiabh H, et al
   Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's Disease.
   Exp Neurol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. WRIGHT JW , Harding JW
   The brain RAS and Alzheimer's disease.
   Exp Neurol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. KAMINSKY YG , Marlatt MW, Smith MA, Kosenko EA, et al
   Subcellular and Metabolic Examination of Amyloid-beta Peptides in Alzheimer Disease Pathogenesis: Evidence for Abeta(25-35).
   Exp Neurol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. BRUNDEN KR , Ballatore C, Crowe A, Smith AB 3rd, et al
   Tau-Directed Drug Discovery for Alzheimer's Disease and Related Tauopathies: A Focus on Tau Assembly Inhibitors.
   Exp Neurol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. SHIRVAN A , Reshef A, Yogev-Falach M, Ziv I, et al
    Molecular imaging of neurodegeneration by a novel cross-disease biomarker.
    Exp Neurol. 2009;219:274-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
11. GOLDE TE , Petrucelli L, Lewis J
    Targeting Abeta and tau in Alzheimer's disease, an early interim report.
    Exp Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. LAZAROV O , Marr RA
    Neurogenesis and Alzheimer's disease: At the crossroads.
    Exp Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. ZHANG X , Le W
    Pathological Role of Hypoxia in Alzheimer's Disease.
    Exp Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. SANCESARIO GM , Esposito Z, Nuccetelli M, Bernardini S, et al
    Abeta1-42 Detection in CSF of Alzheimer disease is influenced by temperature: Indication of reversible Abeta1-42 aggregation?
    Exp Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. LEWCZUK P , Kornhuber J, Vanmechelen E, Peters O, et al
    Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: a multicenter study with multiplexing.
    Exp Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. CHAUDHRY U , Zhuang H, Dore S
    Microsomal Prostaglandin E Synthase-2: Cellular Distribution and Expression in Alzheimer's Disease.
    Exp Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
17. CARDOSO SM , Pereira CF, Moreira PI, Arduino DM, et al
    Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease.
    Exp Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. SAIZ-SANCHEZ D , Ubeda-Banon I, de la Rosa-Prieto C, Argandona-Palacios L, et al
    Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease.
    Exp Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
19. REDDY PH
    Amyloid beta, mitochondrial structural, and functional dynamics in Alzheimer's disease.
    Exp Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. ROBERTS JC , Friel SL, Roman S, Perren M, et al
    Autoradiographical imaging of PPARgamma agonist effects on PBR/TSPO binding in TASTPM mice.
    Exp Neurol. 2009;216:459-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
21. SWERDLOW RH , Khan SM
    The Alzheimer's disease mitochondrial cascade hypothesis: An update.
    Exp Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
22. HERRING A , Ambree O, Tomm M, Habermann H, et al
    Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology.
    Exp Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
23. WALKER DG , Dalsing-Hernandez JE, Campbell NA, Lue LF, et al
    Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation.
    Exp Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. RIBES D , Colomina MT, Vicens P, Domingo JL, et al
    Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease.
    Exp Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. PATEL JR , Brewer GJ
    Age-related differences in NFkappaB translocation and Bcl-2/Bax ratio caused by TNFalpha and Abeta42 promote survival in middle-age neurons and death in old neurons.
    Exp Neurol. 2008;213:93-100.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. TANG SC , Lathia JD, Selvaraj PK, Jo DG, et al
    Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal.
    Exp Neurol. 2008;213:114-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
27. ROSENMANN H , Grigoriadis N, Eldar-Levy H, Avital A, et al
    A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Exp Neurol. 2008;212:71-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. GASPARINI L , Dityatev A
    Beta-amyloid and glutamate receptors.
    Exp Neurol. 2008;212:1-4.
    PubMed     Text format     Related articles   
    
    
    April 2008
29. MCGEER PL , McGeer EG
    The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease.
    Exp Neurol. 2008;.
    PubMed     Text format     Related articles   
    
    
    March 2008
30. PARAMESHWARAN K , Dhanasekaran M, Suppiramaniam V
    Amyloid beta peptides and glutamatergic synaptic dysregulation.
    Exp Neurol. 2008;210:7-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
31. HUA X , Lei M, Ding J, Han Q, et al
    Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with d-galactose: A potential contribution to Alzheimer's disease processes.
    Exp Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2007
32. SCHAPANSKY J , Olson K, Van Der Ploeg R, Glazner G, et al
    NF-kappaB activated by ER calcium release inhibits Abeta-mediated expression of CHOP protein: enhancement by AD-linked mutant presenilin 1.
    Exp Neurol. 2007;208:169-76.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: